GranuFlo and NaturaLyte, both products manufactured by Fresenius and used in kidney dialysis procedures, have been linked to serious blood irregularity side effects. The numerous product liability lawsuits filed against the manufacturer were recently consolidated in Multidistrict Litigation in Massachusetts to resolve common questions of fact. Metabolic Alkalosis Injuries Being Investigated Lawsuits filed against manufacturer […]
A newly widowed woman has filed a wrongful death lawsuit against Fresenius Medical Care North America alleging that her late husband suffered a heart attack and died following hemodialysis treatment using GranuFlo – a liquid given to dialysis patients to replace amino acids that are lost during the hemodialysis process. This widow’s story is becoming […]
More and more product liability lawsuits are being filed against GranuFlo and NaturaLyte manufacturer, Fresenius, as patients subjected to these dangerous dialysate solutions used in kidney dialysis machines are being injured – or dying. A South Carolina son whose father died during a routine kidney dialysis session in which GranuFlo was used has filed the […]
Millions of Americans undergo kidney dialysis, or hemodialysis, every day. While the procedure may be time consuming; it is generally thought to be safe. Until now. GranuFlo and NaturaLyte, two dialysate chemical solutions used in thousands of kidney dialysis centers, have been linked to metabolic alkalosis – a condition associated with low blood pressure, cardiac […]
A widow in Ohio filed a wrongful death lawsuit in November alleging that her husband’s fatal heart attack during kidney dialysis treatment was caused by Fresenius Medical Care’s failure to provide adequate warnings about the side effects of Granuflo, a dialysis product. As a product liability attorney who is investigating claims of serious and fatal […]
Patients undergoing kidney dialysis should not have to wonder whether the medications they are receiving are safe. But an FDA investigation of one of the largest operators of dialysis centers and a major supplier of dialysis products raises serious safety concerns. This year, the FDA issued a Class I recall of dialysis drugs Granuflo and […]